Veritas in Non-Bridging Ventral Hernia Repair (VIBE)
This study is currently recruiting participants.
Verified April 2012 by Synovis Surgical Innovations
Sponsor:
Synovis Surgical Innovations
Information provided by (Responsible Party):
Synovis Surgical Innovations
ClinicalTrials.gov Identifier:
NCT01426477
First received: August 29, 2011
Last updated: April 5, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The main study objective is to determine the frequency of hernia recurrence following use of Veritas Collagen Matrix.
| Condition |
|---|
|
Hernia |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Veritas in Non-Bridging Ventral Hernia Repair |
Resource links provided by NLM:
Genetics Home Reference related topics:
abdominal wall defect
MedlinePlus related topics:
Hernia
U.S. FDA Resources
Further study details as provided by Synovis Surgical Innovations:
Primary Outcome Measures:
- Hernia recurrence [ Time Frame: 5 Years ] [ Designated as safety issue: No ]Recurrence will be evaluated through physical exam and/or CT scans at all study visits (30 days, 6 months, 1 year, 2 years, 3 years, 4 years and 5 years), or when patients present with symptoms, with primary endpoint at 5 years.
Secondary Outcome Measures:
- Number of Medical and Surgical Complications [ Time Frame: 5 years ] [ Designated as safety issue: Yes ]Medical and Surgical Complications, including seroma, wound infection or other concurrent infection, hematoma, fistula, ileus, skin necrosis, wound dehiscence, or any other device-related events, will be evaluated through physical exam and/or CT scans at 30 days, 6 months, 1 year, 2 years, 3 years, 4 years and 5 years, or when patients present with symptoms. These will be reported as total number of each complication within the total number of patients.
- Change in Quality of Life [ Time Frame: Baseline to 5 Years ] [ Designated as safety issue: No ]Patients will complete questionnaires regarding physical functioning including activities of daily living, work productivity, and patient comfort at vartious timepoints after implant at baseline, and at all follow-up visits. Outcomes will be reported in the change from baseline to 5-years.
| Estimated Enrollment: | 100 |
| Study Start Date: | August 2011 |
| Estimated Study Completion Date: | August 2017 |
| Estimated Primary Completion Date: | August 2017 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Veritas Collagen Matrix
Observational study of subjects who undergo open ventral hernia repair using Veritas Collagen Matrix in an underlay technique.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Study surgeons will recruit patients from within their own practice, or through their typical referring sources.
Criteria
Inclusion Criteria:
- Must be 18 years of age or older
- Must be scheduled for open abdominal surgery for repair of primary ventral hernia or first recurrence of a ventral hernia with the Veritas Collagen Matrix using the underlay technique, with our without component separation
- Must be of ambulatory status
- Primary closure can be obtained during surgery
- Repair is such that one piece of Veritas can be used to reinforce the repair
Exclusion Criteria:
- Hernia is undetectable on physical exam
- There is evidence of existing cancer
- BMI ≥ 40
- Use of chronic immunosuppressive therapy, including steroids or cytotoxic agents
- Sensitivity to bovine products
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01426477
Contacts
| Contact: Lisa Draper | 651-796-7511 | lisa.draper@synovissurgical.com |
Locations
| United States, Florida | |
| Watson Clinic Center for Research | Recruiting |
| Lakeland, Florida, United States, 33805 | |
| United States, Georgia | |
| Atlanta Colon & Rectal Surgery, P.A. | Recruiting |
| Atlanta, Georgia, United States, 30274 | |
Sponsors and Collaborators
Synovis Surgical Innovations
More Information
No publications provided
| Responsible Party: | Synovis Surgical Innovations |
| ClinicalTrials.gov Identifier: | NCT01426477 History of Changes |
| Other Study ID Numbers: | 09-004 |
| Study First Received: | August 29, 2011 |
| Last Updated: | April 5, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Synovis Surgical Innovations:
|
Ventral hernia Abdominal wall hernia Incisional hernia |
Biologic mesh Veritas Collagen Matrix Veritas |
Additional relevant MeSH terms:
|
Hernia Hernia, Ventral Pathological Conditions, Anatomical Hernia, Abdominal |
ClinicalTrials.gov processed this record on May 19, 2013